HRMY Harmony Biosciences Holdings, Inc.

NASDAQ

$41.26

Harmony Biosciences Holdings, Inc. (HRMY) Earnings News

Earnings press releases, previews and reviews for Harmony Biosciences Holdings, Inc. (HRMY), newest first.

Tuesday August 4, 2026 7:30 AM ET

Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile

Tuesday July 21, 2026 8:05 AM ET

Harmony Biosciences To Report Second Quarter 2026 Financial Results On August 4, 2026

Thursday July 16, 2026 8:30 AM ET

Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition

Thursday May 7, 2026 7:30 AM ET

Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities

Thursday April 23, 2026 8:05 AM ET

Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026

Tuesday April 14, 2026 8:05 AM ET

Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer